Ngx-1998
Pain
NeurogesXPhase 2Dormant
B
57/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 42/ 100
- Competitive Position
- 81/ 100
Competitive context
44 Active assets in the Pain cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
NEPENTHE Bursa City Hospital | Phase 4 | BBB |
Tapentadol Grünenthal GmbH | Phase 4 | BBB |
Oxycodone The First Affiliated Hospital with Nanjing Medical University | Phase 4 | BBB |
FENTANYL Aga Khan University | Phase 4 | BBB |
Nabiximols Jazz Pharmaceuticals | Phase 3 | BBB |
View all 50 →
Same molecule, other indications
Ngx-1998 is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →